Delivery Order SPE2DR25D1053-SPE2DR26FT821
- Not listed
- The Defense Logistics Agency awarded a $2,910.13 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tranexamic 1,000 mg/100 mL-NaCl 100 mL, a hemostatic agent commonly used in military and medical settings to reduce bleeding. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,723.72 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride 100 mL vials. Issued on September 12, 2025, with an ultimate completion date of September 15, 2025, this firm fixed-price delivery order represents a competitively awarded non-set-aside contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 3, 2025, for Tranexamic 1,000 mg/100ml-NaCl 100ml pharmaceutical supplies, with a ceiling value of $1,202.94 and firm fixed pricing. The delivery order is not set-aside and is scheduled for ultimate completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement for a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,489.51 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride solution (100 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 6, 2025, and performance at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $2,029.56 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Tranexamic 1,000 mg/100ml with Sodium Chloride 100ml, with an ultimate completion date of September 18, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tranexamic 1,000 mg/100 mL in 100 mL saline solution vials. This is a firm fixed-price delivery order valued at $2,039.66, with an ultimate completion date of September 25, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,105.63 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1000mg in quantities of 10 units. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 11, 2025, represents a non-competitive award to the prime contractor under an existing contract vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Tranexamic 1000MG 10S pharmaceutical products. The contract carries a ceiling value of $14,896.27 under a firm fixed-price arrangement, with performance completed by August 29, 2025. This non-set-aside contract is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the vendor maintains its primary...
- This federal contract award is for the delivery of 4,566,775,344 units of Tranexamic 1,000 mg/100 ml-Nacl 100 ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,044.40 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 20, 2024 with a completion date of December 23, 2024. The contract is not designated as a set-aside. It is a delivery order under an Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency Troop Support Medical awarded a $323,150 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100ml bottles of tranexamic acid. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA Troop Support and its customers. Performance will take place in Conshohocken, Pennsylvania, with all items to be delivered by July 8, 2023. As a leading healthcare services...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT821Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Tranexamic 1,000 mg/100mL-NaCl 100mL, a pharmaceutical product used primarily for hemorrhage control and bleeding management in military and medical settings. This firm fixed price delivery order, valued at $1,023.95, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The award was competitively awarded with no set-aside designation and is scheduled for completion by November 13, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's critical role as a prime pharmaceutical vendor supporting the Defense Health Agency and broader military healthcare operations. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts covering brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The company's selection for this IDC vehicle underscores its capability to meet federal procurement requirements through open competition and reflects DLA's strategy of utilizing flexible contract vehicles to ensure reliable pharmaceutical supply chains for military personnel and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/12/25 |